US Edition
Published • loading... • Updated
F.T.C. Settles With Express Scripts Over High Insulin Prices
Summary by Bioethics.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
F.T.C. Settles With Express Scripts Over High Insulin Prices
(New York Times) – The Federal Trade Commission announced on Wednesday that it had reached a settlement with Cigna’s Express Scripts, one of the nation’s largest pharmacy benefit managers, over its role in driving up insulin prices. Express Scripts will not pay a fine or face a financial penalty as part of the settlement and did not admit to any wrongdoing. But the company agreed to a range of changes to its business model. (Read More)
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
